| Dopamine and levodopa prodrugs for the treatment of Parkinson’s disease F Haddad, M Sawalha, Y Khawaja, A Najjar, R Karaman Molecules 23 (1), 40, 2017 | 163 | 2017 |
| A comprehensive review on the anti-cancer effects of oleuropein S Rishmawi, F Haddad, G Dokmak, R Karaman Life 12 (8), 1140, 2022 | 28 | 2022 |
| The efficacy of cannabis on multiple sclerosis-related symptoms F Haddad, G Dokmak, R Karaman Life 12 (5), 682, 2022 | 28 | 2022 |
| A comprehensive review on the efficacy of several pharmacologic agents for the treatment of COVID-19 F Haddad, G Dokmak, R Karaman Life 12 (11), 1758, 2022 | 13 | 2022 |
| A comprehensive review on weight loss associated with anti-diabetic medications F Haddad, G Dokmak, M Bader, R Karaman Life 13 (4), 1012, 2023 | 11 | 2023 |
| Development and optimisation of inhalable EGCG nano-liposomes as a potential treatment for pulmonary arterial hypertension by implementation of the design of experiments approach F Haddad, N Mohammed, RC Gopalan, YA Ayoub, MT Nasim, KH Assi Pharmaceutics 15 (2), 539, 2023 | 6 | 2023 |
| A Comprehensive Review on Therapeutic Potential of Nanobodies F Haddad, G Dokmak, S Kanwal, R Karaman Preprints, 2023 | | 2023 |
| Plasma Protein Binding Refinement of the Extended Clearance Classification System: Subclasses for Predicting Hepatic Uptake or Renal Clearance for Classes 1B and 3B Y Khawaja, F Haddad, H Hallak European Journal of Drug Metabolism and Pharmacokinetics 48 (1), 63-73, 2023 | | 2023 |
| Optimization of the development of Inhalable EGCG nano-Liposome as a Potential Treatment for Pulmonary Arterial Hypertension by Implementation of Design of Experiments Approach F Haddad, N Mohammed, RC Gopalan, MT Nasim, KH Assi | | |
Rafik KaramanDistinguished Professor of Pharmaceutical Sciences, Al-Quds UniversityVerified email at pharm.alquds.edu
